ZVRA FY 2021 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$618M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29M+115.6% YoY

Gross Profit

$27M92.8% margin

Operating Income

$8M27.0% margin

Net Income

-$9M-29.9% margin

EPS (Diluted)

$-2.11

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$133M

Total Liabilities

$6M

Stockholders' Equity

$127M

Cash & Equivalents

$112M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$13M	+115.6%
Gross Profit	$27M	$12M	+121.9%
Operating Income	$8M	-$6M	+237.8%
Net Income	-$9M	-$13M	+33.0%